Anti-angiogenic effects of betulinic acid administered in nanoemulsion formulation using chorioallantoic membrane assay

Journal of Biomedical Nanotechnology

Volumn 7, Issue 2, 2011, Pages 317-324

  Dehelean, Cristina A ^a   Feflea, Stefana ^a   Ganta, Srinivas ^b   Amiji, Mansoor ^b  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Anti Angiogenic effect; Betulinic acid; Chorioallantoic membrane; Nanoemulsion

Indexed keywords

ANGIOGENIC PROCESS; ANTI-ANGIOGENIC ACTIVITY; ANTI-ANGIOGENIC EFFECT; ANTICANCER ACTIVITIES; ANTICANCER COMPOUNDS; BETULINIC ACID; CHICK EMBRYO; CHORIO-ALLANTOIC MEMBRANES; CHORIOALLANTOIC MEMBRANE ASSAYS; DOSE-DEPENDENT MANNER; HIGH PRESSURE HOMOGENIZATION; IN-VIVO; MORPHOLOGICAL CHANGES; NANO-EMULSIONS; NANOEMULSION; NEGATIVE IMPACTS; NORMAL GROWTH; SAMPLE VOLUME; TRITERPENOIDS; TUMOR CELLS;

HOMOGENIZATION METHOD; OILS AND FATS; TUMORS;

CAMS;

BETULIC ACID; SMOOTH MUSCLE ACTIN; ANGIOGENESIS INHIBITOR; NANOMATERIAL; TRITERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CAPILLARY PROLIFERATION; CHICK EMBRYO; CHORIOALLANTOIS; CONTROLLED STUDY; DISPERSION; DRUG FORMULATION; DRUG RESPONSE; DRUG SYNTHESIS; EMBRYO; HYDRODYNAMICS; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MESENCHYME; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PERICYTE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL; ANGIOGENESIS; ANIMAL; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; EMULSION; SOLUBILITY; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DOSE-RESPONSE RELATIONSHIP, DRUG; EMULSIONS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; NANOSTRUCTURES; NEOVASCULARIZATION, PHYSIOLOGIC; SOLUBILITY; TRITERPENES;

EID: 79960995369     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1297     Document Type: Article

References (26)

1. C. A. Dehelean, S. Cinta Pinzaru, C. I. Peev, C. Soica, and D. S. Antal, Characterisation of birch tree leaves, buds and bark dry extracts with antitumor activity. Journal of Optoelectronics and Advanced Materials 9, 783 (2007).
2. P. Yogeeswari and D. Sriram, Betulinic acid and its derivatives: A review on their biological properties. Curr. Med. Chem. 12, 657 (2005).
3. S. Feflea, C. Dehelean, C. Peev, C. Soica, R. Ceausu, and P. Gaje, Betulinic acid and betulin: implications in the angiogenesis process of the chorioallantoic membrane. Revista de Medicinǎ;şi Farmacie-Orvosi es Gyogyszereszeti Szemle 55, 346 (2009).
4. S. Fulda, Betulinic Acid for cancer treatment and prevention. Int. J. Mol. Sci. 9, 1096 (2008).
5. A. Sami, M. Taru, K. Saline, and Y. Jari, Pharmacological properties of the ubiquitous natural product betulin review. Eur. J. Pharm. Sci. 29, 1 (2006).
6. S. Jäger, M. N. Laszczyk, and A. Scheffler, A preliminary pharmacokinetic study of betulin, the main pentacyclic triterpene from extract of outer bark of birch (Betulae alba cortex). Molecules 13, 3224 (2008).
7. F. B. Mullauer, J. H. Kessler, and J. P. Medema, Betulin is a potent anti-tumor agent that is enhanced by cholesterol. PLoS ONE 4, e1 (2009).
8. E. Pisha, H. Chai, I. S. Lee, T. E. Chagwedera, N. R. Farnsworth, G. A. Cordell, and C. W. Beecher, Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1, 1046 (1995).
9. H. J. Kwon, J. S. Shim, J. H. Kim, H. Y. Cho, Y. N. Yum, S. H. Kim, and J. Yu, Betulinic acid inhibits growth factor-induced in vitro angiogenesis via the modulation of mitochondrial function in endothelial cells. Jpn. J. Cancer Res. 93, 417 (2002).
10. M. F. Melzig and H. Bormann, Betulinic acid inhibits aminopeptidase N activity. Planta Medica. 64, 655 (1998).
11. R. Mukherjee, M. Jaggi, P. Rajendran, S. K. Srivastava, M. J. Siddiqui, A. Vardhan, and A. C. Burman, Synthesis of 3-O-acyl/3-benzylidene/3-hydrazone/3- hydrazine/17-carboxyacryloyl ester derivatives of betulinic acid as anti-angiogenic agents. Bioorg. Med. Chem. Lett. 14, 3169 (2004).
12. S. Chintharlapalli, S. Papineni, S. K. Ramaiah, and S. Safe, Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 67, 2816 (2007).
13. D. Ribatti, The chick embryo chorioallantoic membrane in the study of tumor angiogenesis. Romanian Journal of Morphology and Embryology 49, 131 (2008).
14. D. Ribatti, B. Nico, A. Vacca, and M. Presta, The gelatin spongechorioallantoic membrane assay. Nat. Protoc. 1, 85 (2006).
15. S. Ganta and M. Amiji, Coadministration of Paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells. Mol. Pharm. 6, 928 (2009).
16. S. Ganta, H. Devalapally, B. C. Baguley, S. Garg, and M. M. Amiji, Microfluidic preparation of chlorambucil nanoemulsion formulations and evaluation of cytotoxicity and pro-apoptotic activity in tumor cells. J. Biomed. Nanotechnol. 4, 165 (2008).
17. S. Ganta, J. W. Paxton, B. C. Baguley, and S. Garg, Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion. Int. J. Pharm. 360, 115 (2008).
18. S. B. Tiwari and M. M. Amiji, Improved oral delivery of paclitaxel following administration in nanoemulsion formulations. J. Nanosci. Nanotechnol. 6, 3215 (2006).
19. T. K. Vyas, A. Shahiwala, and M. M. Amiji, Improved oral bioavailability and brain transport of Saquinavir upon administration in novel nanoemulsion formulations. Int. J. Pharm. 347, 93 (2008).
20. R. Igarashi, M. Takenaga, and T. Matsuda, Distribution of lipid microsphere preparations. Adv. Drug Deliv. Rev. 20, 147 (1996).
21. N. Weidner, J. Folkman, F. Pozza, P. Bevilacqua, E. N. Allred, D. H. Moore, S. Meli, and G. Gasparini, Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. Journal of the National Cancer Institute 84, 1875 (1992).
22. D. K. Sarker, Engineering of nanoemulsions for drug delivery. Curr. Drug Deliv. 2, 297 (2005).
23. D. P. Rose and J. M. Connolly, Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol. Ther. 83, 217 (1999).
24. H. Maeda and Y. Matsumura, Tumoritropic and lymphotropic principles of macromolecular drugs. Crit. Rev. Ther. Drug Carrier. Syst. 6, 193 (1989).
25. Y. Mizushima and K. Hoshi, Recent advances in lipid microspheres technology for targeting prostaglandin delivery. J. Drug Target 1, 93 (1993).
26. C. A. Dehelean, C. Peev, C. Soica, C. Tatu, S. Cîntǎ;- Pînzaru, and T. A. Gruia, Preliminary in vitro studies on mesenchymal stem cells and melanomacells of dry birch tree extract. Farmacia 55, 696 (2007).